Ophthalmic formulation
US5597559A · kind A · utility
18Cited by
10References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 1994 |
| Grant date | Jan 28, 1997 |
| Priority date | — |
| Expiry date | Oct 26, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0048
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A preservative-free ophthalmic composition useful in the treatment of conditions such as dry eye comprising an aqueous solution of hydroxypropyl methylcellulose, polyethylene glycol, dextrose, potassium chloride, boric acid and sodium borate decahydrate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.